Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-06-09 Novak Rodger Chief Executive Officer Exercise or conversion +1,100 $1.81 $2K 1,216,105
2017-06-09 Novak Rodger Chief Executive Officer Sale −1,100 $15.08 $17K 1,215,005
2017-06-09 Novak Rodger Chief Executive Officer Exercise or conversion · Stock Options (Right to Buy) −1,100 109,140
2017-06-08 Novak Rodger Chief Executive Officer Exercise or conversion +4,203 $1.81 $8K 1,219,208
2017-06-08 Novak Rodger Chief Executive Officer Sale −4,203 $15.00 $63K 1,215,005
2017-06-08 Novak Rodger Chief Executive Officer Exercise or conversion · Stock Options (Right to Buy) −4,203 110,240
2017-05-30 Novak Rodger Chief Executive Officer Exercise or conversion +3,650 $1.81 $7K 1,218,655
2017-05-30 Novak Rodger Chief Executive Officer Sale −3,650 $15.02 $55K 1,215,005
2017-05-30 Novak Rodger Chief Executive Officer Exercise or conversion · Stock Options (Right to Buy) −3,650 114,443
2017-05-17 Novak Rodger Chief Executive Officer Exercise or conversion +25,923 $1.81 $47K 1,240,928
2017-05-17 Novak Rodger Chief Executive Officer Sale −25,923 $16.03 $416K 1,215,005
2017-05-17 Novak Rodger Chief Executive Officer Exercise or conversion · Stock Options (Right to Buy) −25,923 118,093
2017-05-16 Novak Rodger Chief Executive Officer Exercise or conversion +24,077 $1.81 $44K 1,239,082
2017-05-16 Novak Rodger Chief Executive Officer Sale −24,077 $16.50 $397K 1,215,005
2017-05-16 Novak Rodger Chief Executive Officer Exercise or conversion · Stock Options (Right to Buy) −24,077 144,016
2017-05-05 Novak Rodger Chief Executive Officer Exercise or conversion +616 $1.81 $1K 1,215,621
2017-05-05 Novak Rodger Chief Executive Officer Sale −616 $16.92 $10K 1,215,005
2017-05-05 Novak Rodger Chief Executive Officer Exercise or conversion · Stock Options (Right to Buy) −616 168,093
2017-05-04 Novak Rodger Chief Executive Officer Exercise or conversion +13,191 $1.81 $24K 1,229,196
2017-05-04 Novak Rodger Chief Executive Officer Sale −13,191 $16.37 $216K 1,215,005

Page 5 of 6 · 116 trades